In Vitro Diagnostics (IVD) Quality Control Market by Source (Serum, Whole Blood, Urine), Application (Immunoassay, Hematology, Microbiology), Type (Independent Controls, Original Equipment Manufacturers), End User (Hospital, Lab) - Global Forecast to 2025

Abstract
Apex Market Research has published a new report titled ”Global In Vitro Diagnostics (IVD) Quality Control Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global In Vitro Diagnostics (IVD) Quality Control market is estimated to grow from USD 961 billion in 2020 to USD 1158 billion by 2025, at a CAGR of 3.8%. The report offers in-depth insights, revenue details, and other vital information regarding the global In Vitro Diagnostics (IVD) Quality Control market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the In Vitro Diagnostics (IVD) Quality Control market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global In Vitro Diagnostics (IVD) Quality Control market report offers in-depth insights, revenue details, and other vital information regarding the global In Vitro Diagnostics (IVD) Quality Control market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of In Vitro Diagnostics (IVD) Quality Control market. The major players operating into In Vitro Diagnostics (IVD) Quality Control Market include: Bio-Rad Laboratories Inc. (US)
Randox Laboratories Ltd. (UK)
Thermo Fisher Scientific Inc. (US)
Technopath Clinical Diagnostics (Ireland)
Bio-Techne Corporation (US)
Fortress Diagnostics (UK)
Roche Diagnostics (Switzerland)
Siemens Healthineers (Germany)
Danaher Corporation (US)
SeraCare Life Sciences Inc. (US)
Abbott Laboratories Inc. (US)
Sysmex Corporation (Japan)
Ortho-Clinical Diagnostics
Inc. (US)
and Helena Laboratories (US).. Total 25 major players covered Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Product & Service, Application, Manufacturer, End User, and Region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the In Vitro Diagnostics (IVD) Quality Control market to forecast revenues and analyze trends in each of the following submarkets:

By Product & Service

  • Quality Control Products
  • Serum/Plasma-Based Controls
  • Whole Blood-Based Controls
  • Urine-Based Controls
  • Other Source-Based IVD Quality Controls
  • Data Management Solutions
  • Quality Assurance Services

By Application

  • Immunochemistry/Immunoassay
  • Clinical Chemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation & Hemostasis
  • Microbiology
  • Other Applications

By Manufacturer

  • Third-Party Control Manufacturers
  • Independent Controls
  • Instrument-Specific Controls
  • Original Equipment Manufacturers (OEMS)

By End User

  • Hospitals
  • Clinical Laboratories
  • Academic & Research Institutes
  • Other End Users
By geography, this market has been segregated into five regions with revenue and growth rate of In Vitro Diagnostics (IVD) Quality Control from 2020 to 2027,
There are 13 chapters to put on view for In Vitro Diagnostics (IVD) Quality Control Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: In Vitro Diagnostics (IVD) Quality Control Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 In Vitro Diagnostics (IVD) Quality Control Market Overview 1.1.1 In Vitro Diagnostics (IVD) Quality Control Product Scope 1.1.2 Market Status and Outlook 1.2 Global In Vitro Diagnostics (IVD) Quality Control Market Size and Analysis by Regions (2015-2019) 1.2.1 North America In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.2.2 EU In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.2.3 Japan In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.2.4 China In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.2.5 India In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.2.6 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Market Status and Outlook 1.3 Global In Vitro Diagnostics (IVD) Quality Control Market Segment By Product & Service
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Quality Control Products
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 Serum/Plasma-Based Controls
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Whole Blood-Based Controls
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.3.4 Urine-Based Controls
1.3.4.1 Market Estimates And Forecast By Country, 2015-2027
1.3.5 Other Source-Based IVD Quality Controls
1.3.5.1 Market Estimates And Forecast By Country, 2015-2027
1.3.6 Data Management Solutions
1.3.6.1 Market Estimates And Forecast By Country, 2015-2027
1.3.7 Quality Assurance Services
1.3.7.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global In Vitro Diagnostics (IVD) Quality Control Market Segment By Application
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Immunochemistry/Immunoassay
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 Clinical Chemistry
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Hematology
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Molecular Diagnostics
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Coagulation & Hemostasis
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4.6 Microbiology
1.4.6.1 Market Estimates And Forecast By Country, 2015-2027
1.4.7 Other Applications
1.4.7.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global In Vitro Diagnostics (IVD) Quality Control Market Segment By Manufacturer
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.1 Third-Party Control Manufacturers
1.5.1.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Independent Controls
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Instrument-Specific Controls
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Original Equipment Manufacturers (OEMS)
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
1.6 Global In Vitro Diagnostics (IVD) Quality Control Market Segment By End User
1.6.1 Introduction
1.6.1.1 Market Estimates And Forecast 2015-2027
1.6.1 Hospitals
1.6.1.1 Market Estimates And Forecast By Country, 2015-2027
1.6.2 Clinical Laboratories
1.6.2.1 Market Estimates And Forecast By Country, 2015-2027
1.6.3 Academic & Research Institutes
1.6.3.1 Market Estimates And Forecast By Country, 2015-2027
1.6.4 Other End Users
1.6.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global In Vitro Diagnostics (IVD) Quality Control Competition Analysis by Players 2.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Bio-Rad Laboratories Inc. (US) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Bio-Rad Laboratories Inc. (US), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Randox Laboratories Ltd. (UK) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Randox Laboratories Ltd. (UK), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Thermo Fisher Scientific Inc. (US) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Thermo Fisher Scientific Inc. (US), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Technopath Clinical Diagnostics (Ireland) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Technopath Clinical Diagnostics (Ireland), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Bio-Techne Corporation (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Bio-Techne Corporation (US), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Fortress Diagnostics (UK) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Fortress Diagnostics (UK), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Roche Diagnostics (Switzerland) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Roche Diagnostics (Switzerland), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Siemens Healthineers (Germany) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Siemens Healthineers (Germany), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Danaher Corporation (US) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Danaher Corporation (US), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 SeraCare Life Sciences Inc. (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 SeraCare Life Sciences Inc. (US), In Vitro Diagnostics (IVD) Quality Control Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global In Vitro Diagnostics (IVD) Quality Control Market Size Type (2015-2019) 4.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size by Type (2015-2019) Chapter 5 Global In Vitro Diagnostics (IVD) Quality Control Market Size Application (2015-2019) 5.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) 5.2 Potential Application of In Vitro Diagnostics (IVD) Quality Control in Future 5.3 Top Consumer / End Users of In Vitro Diagnostics (IVD) Quality Control Chapter 6 North America In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 6.1 North America In Vitro Diagnostics (IVD) Quality Control Market Size (2015-2019) 6.2 North America In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 7 EU In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 7.1 EU In Vitro Diagnostics (IVD) Quality Control Market Size (2015-2019) 7.2 EU In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 8 Japan In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 8.1 Japan In Vitro Diagnostics (IVD) Quality Control Market Size (2015-2019) 8.2 Japan In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 9 China In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 9.1 China In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2015-2019) 9.2 China In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 10 India In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 10.1 India In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2015-2019) 10.2 India In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 11 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Development Status and Outlook 11.1 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Market Size and Forecast (2015-2019) 11.2 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size (Million USD) by Regions (2020-2027) 12.1. North America In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.1.2 EU In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.1.3 China In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.1.4 Japan In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.1.6 India In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2020-2027) 12.2 Global In Vitro Diagnostics (IVD) Quality Control Market Size by Application (2020-2027) Chapter 13 In Vitro Diagnostics (IVD) Quality Control Market Dynamics 13.1 In Vitro Diagnostics (IVD) Quality Control Market Opportunities 13.2 In Vitro Diagnostics (IVD) Quality Control Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 In Vitro Diagnostics (IVD) Quality Control Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 In Vitro Diagnostics (IVD) Quality Control Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
9327

9995

OUR CLIENT